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Abstract
Background: The xCELLigence real-time cell analysis (RTCA) system is an established electronic cell sensor array. This
system uses microelectronic biosensor technology that is verified for real-time, label-free, dynamic and non-offensive
monitoring of cellular features, including detection of viral cytopathic effect (CPE). Screening viral replication inhibitors
based on presence of CPE has been applied for different viruses, including chikungunya virus (CHIKV). However, most
CPE-based methods, including MTT and MTS assays, do not provide information on the initiation of CPE nor the changes
in reaction rate of the virus propagation over time. Therefore, in this study we developed an RTCA method as an
accurate and time-based screen for antiviral compounds against CHIKV.
Methods: CHIKV-infected Vero cells were used as an in vitro model to establish the suitability of the RTCA system as a
quantitative analysis method based on the induction of CPE. We also performed an MTS assay as a CPE-based
conventional method. Experimental assays were carried out to evaluate the optimal seeding density of the Vero
cells, cytotoxicity of the tested compounds, titration of CHIKV and the antiviral activity of ribavirin, which has
been reported as an effective compound against CHIKV in vitro replication.
Results: The optimal time point for viral inoculation was 18 h after seeding the cells. We determined that the
maximum non-toxic dose (MNTD) of ribavirin was 200 μg/ml for Vero cells. Regarding the dynamic monitoring of
Vero cell properties during antiviral assay, approximately 34 h post-infection, the normalised Cell Index (CI) values
of CHIKV-infected Vero cells started to decrease, while the vehicle controls did not show any significant changes.
We also successfully showed the dose dependent manner of ribavirin as an approved in vitro inhibitor for CHIKV
through our RTCA experiment.
Conclusion: RTCA technology could become the prevailing tool in antiviral research due to its accurate output
and the opportunity to carry out quality control and technical optimisation.
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Background
Chikungunya virus (CHIKV) is an enveloped arbovirus
with a positive-sense single-stranded RNA genome and
belongs to the Togaviridae family [1]. CHIKV is transmit-
ted to humans via bites from infected Aedes mosquitoes.
CHIKV can be detected as early as 4 days post-infection in
the saliva of the mosquitoes, which indicates a short
period of extrinsic incubation [2]. Chikungunya is a
Makonde word for “that which bends up” describing the
contorted posture and unbearably painful rheumatic man-
ifestations experienced by infected patients [3]. Since
2004, millions of cases of CHIKV infection have been re-
ported in the Americas, Africa, Asia, Europe and Indian
Ocean islands [4]. CHIKV outbreaks give rise to a grim
economic burden on the affected regions, especially in the
tropical and sub-tropical parts of the world, as the avail-
able treatment approaches, including fluid transfusion,
bed rest and the use of antipyretics and analgesics can
only alleviate the disease manifestation. In addition, vac-
cines against CHIKV have so far shown to be an intract-
able approach and there are no definite treatments against
CHIKV infections [5]. Therefore, finding effective antiviral
compounds against CHIKV is crucial.
In early studies, the methods and techniques used
to examine antiviral agents included plaque reduction
assay and MTT [3-(4, 5-dimethylthiazol-2-yl)-2, 5-
diphenyltetrazoliumbromide] cell proliferation assay.
Plaque reduction assay is still extensively practised as
the gold standard for quantifying the lytic activity of
viruses, which is observed in an infected confluent cell
through macroscopic analysis of viral plaques prior to dye
staining, with crystal violet, for example. The viral titres
can be efficiently determined using this technique, as an
end-point assay, although the method’s inadequacy re-
garding CPE onset and the kinetics of viral replication is
markedly noted. Furthermore, infections with a dimin-
ished number of viruses and pH of the medium generate
minute unclear plaques that are difficult to detect, or cre-
ate no plaque in spite of virus replication [6].
MTT and MTS cell proliferation assays are enzyme-
based assays that evaluate the activity of mitochondrial
dehydrogenase in cells whereby mitochondrial NADH
condenses MTT and also MTS to purple formazan. Ba-
sically, the colour concentration of formazan dye is asso-
ciated with the number of vital cells [7]. However, these
assays are time consuming in that they are labour inten-
sive, requiring assessment by microscopic observation
for quality control. Hence, an automated assay that moni-
tors the biology of a cell in real-time is sought-after.
The xCELLigence real-time cell analysis (RTCA) system
is an advanced technology, which allows real-time cell
growth monitoring using a label-free cell-based assay that
measures impedance variations in the culture media. This
system has been applied in microbiological research [8],
environmental toxicity [9] and cellular function [10]. De-
tailed and assorted aspects of cellular processes related to
adhesion and morphology of cells, including cytotoxicity,
cell proliferation, receptor-mediated signalling and migra-
tion can be analysed with RTCA [11]. In this system, to
determine electronic impedance, cell culture wells are
equipped with microelectrodes in the base, which attach
to cultured cells through their sensors and record any
changes. The microelectrodes are incorporated in special
cell culture plates, E-Plates. In addition, the electrical im-
pedance measured is based on cell status, termed CI [12].
The electrode impedance is exhibited and set down as the
CI value to exemplify the differences in cell number, adhe-
sion degree, cellular morphology and viability.
In our present study, we aim to investigate the efficacy
of RTCA in the screening of antiviral drugs for CHIKV.
Ribavirin, an approved in vitro inhibitor agent against
CHIKV, was used in our investigation. Ribavirin has
been shown to decrease CHIKV-induced arthritis and
was found to be beneficial in resolving joint and soft tis-
sue swelling [13, 14].
Method
Cell and virus
Vero cells, which are extracted from an African green
monkey kidney-derived cell line CCL81, were obtained
from the ATCC (Manassas, VA, USA). The adherent cell
line was maintained in Eagle’s Minimum Essential
Medium (EMEM; Gibco, Carlsbad, CA, USA) supple-
mented with 10 % foetal bovine serum (FBS; Gibco,
Carlsbad, CA, USA). Cells were cultured in a humidified
atmosphere with 5 % CO2 at 37 °C. The CHIKV strain
used in this experiment was a clinical isolate from an
outbreak in Johor in 2008, coded as MY/065/08/
FN295485. It belongs to the ECSA genotype and has the
A226V mutation in the E1 protein [15]. The CHIKV was
then propagated on Vero cells, followed by the virus, using
tissue culture infectious dose 50 (TCID50) methods [16].
Then, the virus stock was aliquoted and stored at −80 °C
until needed. At the time of virus propagation and antiviral
assays, the percentage of FBS in the cell culture media de-
creased to 2 %.
Chemicals
Ribavirin (Sigma-Aldrich, St. Louis, MO, USA) and cis-
platin (Sigma-Aldrich, St. Louis, MO, USA) were dis-
solved in dimethyl sulfoxide (DMSO, Sigma-Aldrich) to
prepare 50 and 1 mg/ml stock solutions, respectively.
The stock solutions were aliquoted and stored at −20 °C
for future experiments.
Real-time cell analysis system
The RTCA system comprises four main components: an
electronic sensor analyser, a device station, a control unit
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and E-Plate 96. The software used in the study was
RTCA Software 2.0 (Roche), which has the advantages
of a user-friendly interface and electronic recording of
the experimental details. The voltage for the RTCA ana-
lyser was between 100 and 240 V and the frequency was
50 to 60 Hz. The device station, which was placed inside
the incubator, was able to switch any wells from E-plate
96 to the RTCA analyser for the impedance measure-
ment. The CI value was a parameter that reflected the
cell profile based on the impedance measurement. The
CI value was zero in the absence or non-adherence of
cells to the electrodes. In contrast, CI values increased
gradually and consistently as cells attached to the elec-
trodes. Additionally, the CI value measured the adherent
degree of the cells. The degree of cell adhesion can be
categorised into three degrees where a CI value of 1 to 4
is weak, 5 to 10 is considered moderate to strong and 10
to 15 denotes strongly adhered cells [17].
Cell growth and proliferation assay using RTCA
The growth, proliferation and adhesion kinetics of Vero
cells were determined using RTCA technology (ACEA Bio-
sciences, San Diego, CA USA) as previously described with
some minor modifications [18]. Briefly, 50 μl of EMEM
supplemented with 10 % FBS (cell culture medium) was
placed in each well of the E-plate 96 (gold-microelectrode
array integrated E-plate; ACEA Biosciences, San Diego, CA
USA). E-plate 96 was then connected to the system to ob-
tain background impedance readings. This was to ensure
that all wells of E-plate 96 and the connections were in
good condition so as to avoid compromising the interpret-
ation of the results. Serial dilutions of 2.0 × 104, 1.8 × 104
and 1.5 × 104 cells in 50 μl were prepared, four replicates in
each of the concentrations. These serial dilutions of cell
suspensions were added to the wells containing 50 μl of
culture medium. The E-plates were incubated at room
temperature for 30 min in a laminar flow cabinet and then
placed on the RTCA SP Station located in an incubator at
37 °C for continuous impedance recording. CI values mea-
sured by continuous impedance recordings every 2 mi-
nutes reflected the cell activities.
Real-time monitoring of cytotoxicity assay of ribavirin
and virus-induced cytopathogenicity using RTCA
RTCA was used to evaluate the in vitro cytotoxicity of
ribavirin and also CHIKV-induced cytopathogenicity by
profiling the adhesion, growth and proliferation kinetics
of Vero cells in response to treatment. In brief, based on
data from the cell growth and proliferation assay, 1.8 ×
104 cells were seeded in E-plate 96 followed by incuba-
tion at 37 °C with 5 % CO2. Proliferation, spreading and
cell attachment kinetics were monitored every 2 mi-
nutes. When the cells reached the logarithmic growth
phase, two-fold serial dilutions of ribavirin ranging from
200, 100, 50, 25 and 12.5 μg/ml were added to the wells
of E-plate 96 in triplicate. The plate was then incubated
at room temperature for 30 min and then placed on the
RTCA SP Station for continuous impedance recording
every 2 minutes.
As for virus titration assay, CHIKV stock was prepared
in 10-fold dilutions at concentrations of 1 × 10−1, 1 × 10−2,
1 × 10−3, 1 × 10−4, 1 × 10−5 and 1 × 10−6 in EMEM supple-
mented with 2 % FBS. The plate was then incubated at
37 °C for 1 hour followed by washing with sterile PBS
three times to remove the unabsorbed viruses. When the
cells reached the logarithmic growth phase, the cell cul-
ture media in the wells were replaced by 100 μl of viral
suspensions in triplicate. Then, 100 μl of EMEM supple-
mented with 2 % FBS was added to each well and the plate
was placed on the RTCA SP Station at 37 °C with
5 % CO2 for continuous impedance recording every
two minutes.
Real-time cell growth profiling for antiviral assay
using RTCA
RTCA was used to profile the adhesion, growth and pro-
liferation kinetics for antiviral assay. Vero cells were
seeded in E-plate 96 at a concentration determined from
the cell growth and proliferation assay, and incubated at
37 °C. When the cells reached the logarithmic growth
phase, the plate was detached from the RTCA SP Station.
The remaining media were taken out from E-plate 96 and
100 μl virus suspension (MOI = 1) was added to each well.
After 1 hour incubation at 37 °C viral inocula were re-
placed by 200 μl of increasing concentrations of the tested
compounds, accordingly. Depending on the preliminary
cytotoxicity data, ribavirin was prepared in serial dilutions
of 50, 25, 12.5 and 6.25 μg/ml. For vehicle cell control, all
the wells were replaced by adding the 200 μl of cell culture
medium with 2 % FBS. E-Plate 96 was then incubated in
the RTCA SP Station inside the incubator and the CI
values were recorded every 2 minutes.
Investigating acute drug responsiveness by RTCA
As a further study on the rapid detection of cytotoxicity
by RTCA, Vero cells were treated with cisplatin as a
compound with known potent cytotoxicity. The cells
were prepared in EMEM supplemented with 10 % FBS
and seeded in an E-Plate at a density of 1.8 × 104 cells
per well. The cisplatin was prepared in concentrations of
8, 6, 4, 2 and 0.5 μg/ml in EMEM supplemented with
2 % FBS. The plate was then incubated at room
temperature for 30 min after adding the different con-
centrations of cisplatin in triplicate. Then, the plate was
placed on the RTCA SP Station at 37 °C with 5 % CO2
for continuous impedance recording every 2 minutes.
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Cell morphology analysis
As a parallel comparison to both cytotoxicity and anti-
viral assay conducted by RTCA and MTS assay, the Vero
cells were seeded in two different 96-well plates (Nunclon).
The cell morphology was observed through inverted mi-
croscopy prior to MTS assay. The cells were visualised and
their images were captured with a Zeiss Telaval 31 micro-
scope after 72 h of incubation for both cytotoxicity and
antiviral assays.
Cytotoxicity assay of ribavirin and cisplatin using MTS
MTS assay as an approved cytotoxicity test was per-
formed to determine the non-toxic concentrations of
both ribavirin and cisplatin on Vero cells using an
MTS (3-(4, 5-dimethylthiazol-2-yl)-5-(3-carboxymethoxy-
phenyl)-2-(4-sulfophenyl)-2H-tetrazolium) kit (Promega,
USA) according to the manufacturer’s protocol. In short,
the Vero cells were grown in 96-well plates and were
treated with increasing concentrations of ribavirin and cis-
platin in triplicate. The cytotoxicity assay was conducted
for 48 and 72 h post-treatment, respectively. Subsequently,
MTS solution was added to each well and incubated for 4
hours at 37 °C with 5 % CO2 followed by an absorbance
reading at the 490 nm wavelength using Infinite 200
Pro-multiplate reader (Tecan, Männedorf, Switzerland).
Antiviral assay using MTS
To identify the half maximal inhibitory concentration
(IC50) of ribavirin against CHIKV-infected Vero cells,
antiviral assay was conducted by MTS assay (Promega,
USA) according to the manufacturer’s protocol. The
Vero cells were grown in two different 96-well plates
and were treated with different concentrations of ribavi-
rin in triplicate after CHIKV inoculation of the cells.
The plates were then incubated for 48 and 72 h at 37 °C
with 5 % CO2 prior to MTS assay. Subsequently, MTS
solution was added to the cells and incubated for 4
hours at 37 °C with 5 % CO2 followed by an absorbance
reading at the 490 nm wavelength using the Infinite 200
Pro-multiplate reader (Tecan, Männedorf, Switzerland).
Data analysis
The half maximal cytotoxic concentration (CC50) and in-
hibitory concentration (IC50) for the MTS assay was de-
termined by Graph Pad Prism 5 (Graph Pad Software
Inc., San Diego, CA, USA, 2005). A nonlinear regression
was run to evaluate the association between the dose-
dependent manner of the compound and antiviral activ-
ities of Vero cells. For RTCA data analysis, the normalised
CI value was calculated for each sample well by normalis-
ing the CI value to a suitable time point prior to the treat-
ment or infection. Fundamentally, the normalised CI
value, CC50 and IC50 were automatically calculated by
RTCA Software 2.0 (Roche). CI normalisation is essential
to provide an accurate estimation of the percentage of cell
adhesion, as it eliminates redundant data and secures the
loading of the associated data.
Results
Monitoring of cell growth and proliferation
In this study, a cell proliferation analysis was performed
using Vero cells to get the optimum cell number seeded
in E-Plate 96 and to distinguish the optimal time point
for viral infection prior to the antiviral assay. RTCA soft-
ware was used to determine CI values through the mea-
sured impedance recordings.
Three different cell densities of 2.0 × 104, 1.8 × 104 and
1.5 × 104 cells were used in the experiment. As shown in
Fig. 1, the preliminary phase of cell adhesion and prolif-
eration was from 0 to 18 h after cell seeding, indicating
the potential time point for the infection and treatment.
The maximum CI value of 6.56 can be classified as a
moderate to strong degree of cell adhesion (Fig. 1). The
curves for all different densities of seeded Vero cells did
not exhibit significant differences, therefore, as the me-
dian value of three different cell densities, 1.8 × 104 was
selected as the optimum number for cell seeding. The
optimal time point for viral infection of 1.8 × 104 cells
was defined at 18 h after cell seeding.
Cytotoxicity assay of ribavirin and cisplatin
Cytotoxicity assay was performed to identify the CC50 of
the compounds. The cytotoxicity of ribavirin and cis-
platin was analysed by both RTCA and MTS methods. It
was found that there was no significant cytotoxicity for
all tested concentrations of ribavirin in Vero cells. The
optimal treatment time point for both compounds was
at approximately 19 h. The CI value was normalised to
the suitable time point after treatment, which was 26 h,
so as to eliminate the redundant data. The results
showed that more than 90 % of the cells treated with
200 μg/ml of ribavirin were viable (Fig. 2). The curves in
Fig. 2a illustrated by RTCA show that the ribavirin does
not restrict the impedance measurement even at the
highest concentration, which indicates that 200 μg/ml of
ribavirin does not show toxicity in Vero cells. We have
also shown that ribavirin treated-Vero cells do not dis-
play significant changes in cellular morphology (Fig. 3).
The results for cytotoxicity of cisplatin in Vero cells
are illustrated in Fig. 4. It has been shown that approxi-
mately 15 h post-treatment, the CI value of Vero cells
treated with 8 μg/ml of cisplatin start to decline, followed
by cells treated with 6 μg/ml of cisplatin at 21 h post-
treatment (Fig. 4a). The CC50 obtained from RTCA was
5.620 μg/ml for both days two and three post-treatment,
respectively. Nevertheless, the CC50 values resulting from
MTS assay were 3.409 and 0.033 μg/ml for days two and
three post-treatment, respectively (Fig. 4b).
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Antiviral assay of ribavirin against CHIKV
Eighteen hours after cell seeding, Vero cells were infected
with CHIKV followed by treatment with ribavirin. The re-
sults from RTCA showed that the CI values of CHIKV-
infected Vero cells started to decrease 34 h post-infection,
while vehicle controls and treated infected-Vero cells did
not show any significant changes (Fig. 5a). The results also
indicated compliance with the dose-dependent manner
for ribavirin treatment, which was verified by the CI values
of Vero cells-infected with CHIKV. The data from MTS
assay demonstrated that there was no significant change
that could be observed in all concentrations of ribavirin-
treated cells except for in the lowest concentration of riba-
virin (Fig. 5b). This result can also be verified by the cell
morphology profiles in Fig. 6. The MTS result exemplified
that the IC50 for ribavirin at 48 and 72 h were 6.12 and
20.34 μg/ml, respectively. Meanwhile, the IC50 interpreted
by RTCA was 14.78 μg/ml at both 48 and 72 h.
Fig. 2 The Effect of the Intensified Concentrations of Ribavirin on Vero Cells Evaluated by both RTCA and MTS Assays. a The cell proliferation after
138 h of incubation with increasing concentrations of ribavirin. The black vertical line indicates the normalisation of the CI time point at 26 h
subsequent to Vero cells being treated with ribavirin. Coloured curves represent the various serial dilutions of ribavirin. Each data point signifies
the average ± standard deviation and was analysed in triplicate. Blue line: 200 μg/ml ribavirin; Pink line: 100 μg/ml ribavirin; Turquoise line: 50 μg/ml
ribavirin; Purple line: 25 μg/ml ribavirin; Grey line: 12.5 μg/ml ribavirin; Green line: negative control (without ribavirin). Each data point signifies
the average ± standard deviation and was analysed in triplicate. b In comparison to the RTCA assay, this figure indicates that the Vero cells
were viable even when treated at the highest concentration of ribavirin on both days two and three, showing minimal cytotoxic effects of the
compound on the cells via MTS assay
Fig. 1 Proliferation Curve of Vero Cells. The cells that were seeded in E-Plate 96 and were constantly observed by measuring CI values to obtain
the ideal cell number and to distinguish the suitable time point for virus infection prior to the antiviral assay are indicated. Cell features such as
adhesion, spreading and proliferation were observed in intervals of 2 minutes. The dash line marks the initial phase of cell adhesion and spreading
determined by the CI curve of 1.8 × 104 cells at 18 h. Coloured curves represent the various numbers of cells seeded per well in E-Plate 96: Blue line:
2.0 × 104 cells/well; Pink line: 1.8 × 104 cells/well; Turquoise line: 1.5 × 104 cells/well. Each data point signifies the average ± standard deviation and was
analysed in triplicate
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Viral titration assay
Viral titration assay was conducted to verify and opti-
mise the viral dose-dependency of CHIKV on RTCA
technology. As shown in Fig. 7, the graph curves started
to decrease at 18 h after infection for the highest virus
dilution, which was 1 × 10−1,and decreased gradually as
the dilutions increased, exhibiting a dose-dependent
manner for CHIKV infection in Vero cells. The decrease
in CI value indicated cell death as a consequence of
CHIKV replication, while in contrast, vehicle control
and Vero cells infected with 1 × 10−6 dilution of CHIKV
did not show any significant change in CI value (Fig. 7).
In parallel to this experiment, TCID50 of CHIKV was
performed in a 96-well plate for the same series of virus
concentrations. The TCID50 obtained was 10
3.5 EID50/ml
for both RTCA and conventional end-point assay.
Discussion
Nowadays, researchers are adopting advanced technology,
such as label-free detection methodologies for cell-based
experiments [19]. Cellular activities, including growth in-
hibition, shape change, spreading, migration and adhered
cell degree, can be effectively determined by RTCA tech-
nology. Moreover, RTCA is favoured for the efficacy and
safety of the experiments [10]. This technology is reason-
ably consistent and sufficiently dynamic for wide use in
medium-throughput screening.
Therefore, in the present study, we aimed to prove the
ability of RTCA to detect optimal culture conditions and
to examine the reproducibility of cytotoxicity and anti-
viral assays. Based on the cell growth and proliferation
profile measured by RTCA, the curves of initial adhesion
of Vero cells were characterised by the sharp rise in CI
Fig. 3 The Effect of the Intensified Concentrations of Ribavirin on Vero Cell Morphology. The cell morphology profile after 72 h of incubation after
treatment with ribavirin. In parallel comparison to the cytotoxic effect on Vero cells, which was illustrated by RTCA, the cells seeded in a 96-well plate
were observed via microscopy. Two-fold serially diluted ribavirin at concentrations of a 200 μg/ml, b 100 μg/ml, c 50 μg/ml, d 25 μg/ml, e 12.5 μg/ml
and f 6.25 μg/ml were used to treat the Vero cells. As a control, g, three wells of non-treated cells were monitored
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value over the 18 h post-cell seeding and followed by a
proliferation period that started to decrease at approxi-
mately 48 h post-cell seeding. The decrease in CI value
indicated that the cells were not healthy and cell death
was possible. Based on our findings through classic end-
point methods, such as MTT and MTS assays for the
CHIKV antiviral assay, which was 72 h post-infection,
we set up the same end point for the reading of our devel-
oped RTCA method. Information on behaviour, propaga-
tion and fitness of cells through CI value curves was
beneficial and enhanced the experimental design compared
to conventional in vitro methods, such as MTT and MTS
assays whereby the treatments were commonly introduced
at a certain time point, technically 24 h after cell seeding in
the plates [13].
As reported by Briolant et al. ribavirin is known as an
effective antiviral agent against CHIKV in vitro replica-
tion with minimal cytotoxic effects on Vero cells. The
results obtained from both methods used in this study
showed no cytotoxicity for ribavirin on Vero cells up to
200 μg/ml of the compound. Cisplatin is a chemother-
apy drug widely used to treat different types of cancers
Fig. 4 The Effect of the Intensified Concentrations of Drug-Induced Cytotoxicity on Vero Cells Evaluated by both RTCA and MTS Assays. a Vero
cell profile after 138 h of incubation with increasing concentrations of cisplatin. The black vertical line indicates the normalisation of the CI time
point at 26 h subsequent to Vero cells being treated with cisplatin. Coloured curves represent the various concentrations of cisplatin. Each data
point signifies the average ± standard deviation and was analysed in triplicate. Blue line: 8 μg/ml cisplatin; Pink line: 6 μg/ml cisplatin; Turquoise
line: 4 μg/ml cisplatin; Purple line: 2 μg/ml cisplatin; Grey line: 0.5 μg/ml cisplatin; Green line: negative control (without cisplatin). Each data point
signifies the average ± standard deviation and was analysed in triplicate. b Illustration of the curve of cisplatin effects on Vero cells at 48 and 72 h
via MTS assay
Fig. 5 The Antiviral Effect on Vero Cells Infected with CHIKV Evaluated by both RTCA and MTS Assays. a Measurement of cell impedance every 2
minutes by RTCA monitored the antiviral effect of the various concentrations of ribavirin on the proliferation, spreading and adhesion of cells. The
black vertical line indicates the normalisation of the CI time point at 26 h subsequent to treatment of infected Vero cells with ribavirin. The red
dash line indicates the onset of declined curved due to infectivity of CHIKV and antiviral activity on Vero cells. Coloured curves represent the Vero
cells, viral infected Vero cells and treated viral infected Vero cells with different concentrations of ribavirin. Blue line: 50 μg/ml ribavirin; Pink line:
25 μg/ml ribavirin; Turquoise line: 12.5 μg/ml ribavirin; Purple line: 6.25 μg/ml ribavirin; Red line: positive control (CHIKV infection); Green line:
negative control (without CHIKV infection). Each data point signifies the average ± standard deviation and was analysed in triplicate. b The curve
shows the antiviral activity effects via MTS assays, which can only be obtained at 48 and 72 h prior to ribavirin treatment of CHIKV-infected
Vero cells
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such as sarcoma, lung cancer and ovarian cancer. But it
can become toxic at certain concentrations for differ-
ent cells. Therefore, we used cisplatin as a control with
known cytotoxicity. Our cytotoxicity evaluation of cis-
platin through the RTCA method showed the efficacy
and sensitivity of RTCA in detecting cytotoxic effects
in a real-time monitoring frame and a well-defined
dose-dependent manner.
In this study, we observed different times of onset of
CPE for both RTCA and MTS assay as a conventional
end-point assay. The time point for onset of CPE for
antiviral assay evaluated by RTCA was at approximately
14 h earlier compared to the MTS. The curve generated
by the RTCA software showed a decline at 34 h post-
infection, while for the MTS assay, at least 48 h passed
before significant changes could be identified through
the absorbance reading. The IC50 of the conventional
assay exhibited vast differences between both days of
treatment compared to the IC50 computed by RTCA,
which showed a consistent and precise result through
real-time monitoring. The graph from the MTS assay
did not show resilient significant changes in ribavirin
treatment at 48 and 72 h. However, we observed a dose-
dependent manner curve in RTCA analysis after ribavirin
Fig. 6 The Antiviral Effect on Vero Cell Morphology. Cell morphology profile after 72 h post infection and treatment. In parallel comparison to the
antiviral effect on Vero cells, which was indicated by RTCA, the cells were seeded in a 96-well plate and observed via microscopy. CHIKV-infected
cells were treated with ribavirin at concentrations of a 50 μg/ml, b 25 μg/ml, c 12.5 μg/ml, and d 6.25 μg/ml. As a virus control, three wells of
non-treated CHIKV-infected cells, (e), were used. As vehicle control, three wells of non-infected Vero cells, (f), were monitored
Fig. 7 The Viral Titration of Vero Cell Infected with CHIKV Evaluated by RTCA. Measuring cell impedance every 2 minutes by RTCA monitored the
viral dose-dependency effect of various dilutions of CHIKV inoculum on the proliferation, spreading and adhesion of cells. The black vertical line
indicates the normalisation of the CI time point at 26 h subsequent to CHIKV infection of the Vero cell line. Coloured curves represent the Vero
cells infected with different concentrations of CHIKV. Blue line: 10−1 CHIKV; Pink line: 10−2 CHIKV; Turquoise line: 10−3 CHIKV; Purple line: 10−4
CHIKV; Grey line: 10−5 CHIKV and Orange line: 10−6 CHIKV; Green line: negative control (without CHIKV infection). Each data point signifies the
average ± standard deviation and was analysed in triplicate
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treatment for CHIKV-infected Vero cells, as the CI value
started to decrease at approximately 34 h post infection
and treatment. This finding indicated that RTCA tech-
nology was capable of detecting real-time changes in
quantification of virus-induced CPE and the behaviour
of the cellular mechanism when exposed to a drug or
compound, which cannot be observed through the con-
ventional methods.
Cell quality control and stability are major concerns
due to the amplified dependence on cells in drug dis-
covery [20, 21]. In traditional methods, phenotypic ana-
lysis and viability are examined by microscopy and dye
staining techniques, which, in addition to being time-
consuming, are mainly carried out at a single time
point. Kirstein et al. [20] have shown similar prolifera-
tion kinetic profiles for various cell types, which ex-
plains a quantitative account of their cellular behaviour.
In comparison to conventional cell-based assays, RTCA
is a practical method whereby all the information regard-
ing cell activities throughout the incubation period is
automatically recorded and monitoring is continuous.
As a diagnostic tool, this information can be effectively
used for cellular quality control, which could be measured
based on the RTCA technology. To encourage more in-
vestigators to use RTCA in primary toxicity screening,
emphasising the close correlation between cellular imped-
ance measurements with numerous compounds is consid-
ered to be vital. However, the limited usage of RTCA
assay, which works best with adhered cells and comes at a
great expense in comparison with traditional facilities, is a
restricting factor for RTCA.
Conclusion
In conclusion, regardless of restrictions, RTCA technology
seems to be a prevailing and trustworthy tool in research
innovation due to the realistic throughput, the opportunity
to carry out quality control and technical optimisation,
and the likelihood of analysing real-time cell reactions to
antiviral agents for the development of pharmaceutical
products in the early stages [22]. This system can produce
predictive facts at the hit-to-lead phase and as a result, di-
minish the destruction rate due to the safety and efficacy
associated with substantial savings for the advanced stages
of antiviral drug development [23]. In addition, unlike the
conventional end-point assays, RTCA provides time-based
biological information at the interface between cells
and toxicants.
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